Safety and efficacy of acellular pertussis vaccine in Japan, evaluated by 23 years of its use for routine immunization

Pediatrics International

Volumn 46, Issue 6, 2004, Pages 650-655

  Kuno Sakai, Harumi ^a   Kimura, Mikio ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Acellular; Encephalopathy; Epidemiology of pertussis; Neurological illnesses; Pertussis vaccine

Indexed keywords

ACELLULAR VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTUSSIS VACCINE; UNCLASSIFIED DRUG; WHOLE CELL PERTUSSIS VACCINE;

ANAPHYLAXIS; ARTICLE; ATAXIA; BRAIN DISEASE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONVULSION; DEHYDRATION; DIARRHEA; DIPHTHERIA; DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ENCEPHALITIS; EPILEPTIC STATE; FACIAL NERVE PARALYSIS; FEBRILE CONVULSION; FEVER; GOVERNMENT; GUILLAIN BARRE SYNDROME; HEMIPLEGIA; HUMAN; IMMUNIZATION; INFANT; INFANTILE SPASM; JAPAN; NEUROLOGICAL COMPLICATION; PERTUSSIS; PRIORITY JOURNAL; PURPURA; RASH; SIDE EFFECT; SUDDEN DEATH; TETANUS; URTICARIA; VACCINATION;

AGE DISTRIBUTION; CHILD HEALTH SERVICES; CHILD, PRESCHOOL; CONSUMER PRODUCT SAFETY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INCIDENCE; INFANT; JAPAN; MALE; PERTUSSIS VACCINE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; VACCINES, ACELLULAR; WHOOPING COUGH;

EID: 11944249888     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-200x.2004.01970.x     Document Type: Article

References (18)

1. Sato Y, Kimura M, Fukumi H. Development of a pertussis component vaccine in Japan. Lancet 1984; 1:8369: 122-6.
2. Kimura M, Hikino N. Results with a new DTP vaccine in Japan. Dev. Biol. Stand. 1985; 61: 545-61.
3. WHO. WHO Position Paper on pertussis vaccines, CV1/WHO informal consultation on control, of pertussis with whole cell and acellular vaccines. 18-19 May, 1998; Geneva, Room M305.
4. Kuno-Sakai H, Kimura M. Verification of components of acellular pertussis vaccines that have been distributed solely, been in routine use for the last two decades and contributed greatly to control of pertussis in Japan. Biologicals 2004; 32: 29-35.
5. Kuno-Sakai H, Kimura M. Japanese clinical trials with Takeda acellular pertussis vaccine. Tokai J. Exp. Clin. Med. 1988; 13 (Suppl.): 15-19.
6. Mortimer EA, Kimura M, Cherry JD et al. Protective efficacy of the Takeda acellular pertussis vaccine combined with diphtheria and tetanus toxoids following household exposure of Japanese children. Am. J. Dis. Child. 1990; 144: 899-904.
7. Kimura M, Kuno-Sakai H, Sato Y et al. A comparative trial of the reactogenicity and immunogenicity of Takeda acellular pertussis vaccine combined with tetanus and diphtheria toxoids. Am. J. Dis. Child. 1991; 145: 734-41.
8. Kuno-Sakai H, Kimura M, Ohta K et al. A simple and sensitive ELSA of antibodies to pertussis antigens. Vaccine 1992; 10: 350-2.
9. Kimura M, Kuno-Sakai H, Kamiya H et al. Immugenicity and reactogenicity of the component pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous haemagglutinin. Acta Paediatr. Jpn. 1995; 37: 562-674.
10. Kimura M, Kuno-Sakai H. Epidemiology of pertussis in Japan. Tokai J. Exp. Clin. Med. 1988; 13 (Suppl.): 1-7.
11. Kimura M, Kuno-Sakai H. Experiences with acellular pertussis vaccine in Japan and epidemiology of pertussis. Tokai J. Exp. Clin. Med. 1987; 12: 263-73.
12. Kimura M, Kuno-Sakai H. Pertussis vaccines in Japan. Acta Paediatr. Jpn. 1988; 30: 143-53.
13. Kimura M, Kuno-Sakai H. Developments in pertussis immunisation in Japan. Lancet 1990; ii: 30-2.
14. Kimura M, Kuno-Sakai H. Current epidemiology of pertussis in Japan. Pediatr. Infect. Dis. J. 1990; 9: 705-9.
15. Kimura M, Kuno-Sakai H. Pertussis vaccines in Japan - a clue towards understanding of Japanese attitude of vaccines. J. Trop. Pediatr. 1991; 37: 45-7.
16. Kuno-Sakai H, Kimura M. Epidemiology of pertussis and use of acellular pertussis vaccines in Japan. In: Brown F, Greco D, Mastrantonio P, Salmaso S, Wassilak S (eds). Pertussis Vaccine Trials. Karger, Basel 1997; 331-2.
17. Official documents related with pertussis and pertussis vaccine. May 1975. Published by the Research Team on Adverse Events of Immunization, Ministry of Health, Labor and Welfare, Japan and Immunization. Research Center supported by Ministry of Health, Labor and Welfare, Japan, p. 12 [in Japanese].
18. Kuno-Sakai H, Kimura M. Severe neurological illnesses following administration of pertussis vaccines. In: Fukuyama Y, Kamoshita S, Ohtsuka C, Suzuki Y (eds). Modern Perspectives of Child Neurology. The Japanese Society of Child Neurology, Tokyo, 1991; 141-7.